SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
DANAHER CORP /DE/

(Last) (First) (Middle)
2200 PENNSYLVANIA AVE, N.W., SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/17/2021
3. Issuer Name and Ticker or Trading Symbol
Codex DNA, Inc. [ DNAY ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 2,294,157 I By Danaher Innovation Center LLC(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
DANAHER CORP /DE/

(Last) (First) (Middle)
2200 PENNSYLVANIA AVE, N.W., SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Danaher Innovation Center LLC

(Last) (First) (Middle)
C/O DANAHER CORPORATION
2200 PENNSYLVANIA AVE, N.W., SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
Explanation of Responses:
1. Consists of 2,294,157 shares held of record by Danaher Innovation Center LLC. Danaher Innovation Center LLC is an indirect, wholly owned subsidiary of Danaher Corporation. The address of Danaher Innovation Center LLC is 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC 20037.
Remarks:
Danaher Corporation /s/ James F. O'Reilly, Vice President, Deputy General Counsel and Secretary 06/17/2021
Danaher Innovation Center LLC /s/ James F. O'Reilly, Vice President and Secretary 06/17/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.